Chembio Diagnostics Inc.

NASDAQ:CEMI   3:59:56 PM EDT
1.01
0.00 (-0.50%)
Products

Chembio Diagnostics Says FDA Declined To Review Co's Application For EUA For DPP Respiratory Antigen Panel

Published: 12/28/2021 22:36 GMT
Chembio Diagnostics Inc. (CEMI) - Chembio Diagnostics Inc - on December 21, FDA Notified Co That It Was Declining to Review Co's Application for Eua for Dpp Respiratory Antigen Panel.
Chembio -fda Notice Said Co Will Need to Collect Influenza a & Influenza B Samples, Submit New Eua Application for Dpp Respiratory Antigen Panel.